Category: Cancer Treatment
Cancer Treatment market research reports by GlobalData
-
Non-Small Cell Lung Cancer (NSCLC): Epidemiology Forecast to 2032
Non-Small Cell Lung Cancer (NSCLC): Epidemiology Forecast to 2032 Summary Non-small cell lung cancer (NSCLC) is the most common type of lung cancer, accounting for approximately 85% of all lung cancer cases (National Cancer Institute, 2020). NSCLC begins when healthy cells that make up the lining of ... Read More
-
Ovarian Cancer Opportunity Assessment and Forecast
Ovarian Cancer Opportunity Assessment and Forecast Summary This report includes an assessment of the disease epidemiology and 10-year patient-based forecast (PBF) across the 7MM for marketed and late-stage pipeline therapies, with a launch date assessment by market for Ovarian Cancer. These sales fo ... Read More
-
Thematic Intelligence - Biosimilars in oncology
Thematic Intelligence - Biosimilars in oncology Summary Clients will gain insight into the percentage of cancer patients treated with biosimilars, the price of these agents compared to their originator, and key opinion leaders’ outlook for the products. The report includes the 8MM regulatory landsca ... Read More
-
Waldenstrom Macroglobulinemia (Lymphoplasmacytic Lymphoma) - Global Clinical Trials Review, 2023
Waldenstrom Macroglobulinemia (Lymphoplasmacytic Lymphoma) - Global Clinical Trials Review, 2023 Summary GlobalData's clinical trial report, “Waldenstrom Macroglobulinemia (Lymphoplasmacytic Lymphoma) Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update pro ... Read More
-
Gallbladder Cancer - Global Clinical Trials Review, 2023
Gallbladder Cancer - Global Clinical Trials Review, 2023 Summary GlobalData's clinical trial report, “Gallbladder Cancer Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update provides an overview of Gallbladder Cancer Clinical trials scenario. This report pr ... Read More
-
Hepatocellular Carcinoma - Global Clinical Trials Review, 2023
Hepatocellular Carcinoma - Global Clinical Trials Review, 2023 Summary GlobalData's clinical trial report, “Hepatocellular Carcinoma Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update provides an overview of Hepatocellular Carcinoma Clinical trials scenar ... Read More
-
Anal Cancer (AC) - Competitive Landscape
Anal Cancer (AC) - Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in AC therapeutics. More than 33,000 diagnosed incident cases of AC are anticipated in 2023 in the 16 countries covered in GlobalData’s epidemiology forecast ... Read More
-
Digital Marketing Trends in Non-small Cell Lung Cancer
Digital Marketing Trends in Non-small Cell Lung Cancer Summary Merck’s Keytruda.com achieved the highest total traffic across non-small cell lung cancer (NSCLC) patient sites in the US, with over 2.4 million visitors from October 2022 to September 2023. This was followed by BMS's Opdivo.com (1.7 mil ... Read More
-
Colorectal Cancer Screening Tests Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies
Colorectal Cancer Screening Tests Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies Summary GlobalData's Medical Devices sector report, “Colorectal Cancer Screening Tests Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory ... Read More
-
Cervical Cancer Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update
Cervical Cancer Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update Summary GlobalData's clinical trial report, “Cervical Cancer Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2023 U ... Read More
-
Ewing Sarcoma Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update
Ewing Sarcoma Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update Summary GlobalData's clinical trial report, “Ewing Sarcoma Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2023 Updat ... Read More
-
Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update
Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update Summary GlobalData's clinical trial report, “Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) Clinical Trial Analysis by Trial ... Read More
-
Digital Marketing Trends in Colorectal Cancer
Digital Marketing Trends in Colorectal Cancer Summary Merck’s Keytruda.com achieved the highest total traffic across CRC patient sites in the US, with over 3.3 million visitors from August 2022 to July 2023. This was followed by BMS’s Opdivo.com (1.7 million visits) and Roche’s Avastin.com (258,000 ... Read More
-
Chronic Lymphocytic Leukemia (CLL) Market Opportunity Assessment, Epidemiology, Clinical Trials, Unmet Needs and Forecast to 2032
Chronic Lymphocytic Leukemia (CLL) Market Opportunity Assessment, Epidemiology, Clinical Trials, Unmet Needs and Forecast to 2032 Summary This report covers the 7MM (US, France, Germany, Italy, Spain, UK, and Japan) and includes an assessment of the disease epidemiology and 10-year patient-based for ... Read More
-
Australia Speech Aid Devices Procedures Count by Segments and Forecast to 2030
Australia Speech Aid Devices Procedures Count by Segments and Forecast to 2030 Summary GlobalData’s “Australia Speech Aid Devices Procedures Outlook to 2030” is a comprehensive databook report, covering key procedures data on the Australia Speech Aid Devices Procedures. The databook report provides ... Read More
-
India Speech Aid Devices Procedures Count by Segments and Forecast to 2030
India Speech Aid Devices Procedures Count by Segments and Forecast to 2030 Summary GlobalData’s “India Speech Aid Devices Procedures Outlook to 2030” is a comprehensive databook report, covering key procedures data on the India Speech Aid Devices Procedures. The databook report provides procedure vo ... Read More
-
Acute Myeloid Leukemia (AML) Market Opportunity Assessment, Epidemiology, Clinical Trials, Unmet Needs and Forecast to 2032
Acute Myeloid Leukemia (AML) Market Opportunity Assessment, Epidemiology, Clinical Trials, Unmet Needs and Forecast to 2032 Summary This report covers the 8MM (US, France, Germany, Italy, Spain, UK, Japan, and China) and includes an assessment of the disease epidemiology and 10-year patient-based fo ... Read More
-
Diffuse Large B-Cell Lymphoma (DLBCL) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
Diffuse Large B-Cell Lymphoma (DLBCL) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in DLBCL therapeutics. More than 555,000 diagnosed prevalent cases of DLBCL are ... Read More
-
Cutaneous Squamous Cell Carcinoma (cSCC) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
Cutaneous Squamous Cell Carcinoma (cSCC) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in cSCC therapeutics. More than 16 million diagnosed prevalent cases of DN a ... Read More
-
BRCA Tests Market Size (Value, Volume, ASP) by Segments, Share, Trend and SWOT Analysis, Regulatory and Reimbursement Landscape, Procedures, and Forecast to 2033
BRCA Tests Market Size (Value, Volume, ASP) by Segments, Share, Trend and SWOT Analysis, Regulatory and Reimbursement Landscape, Procedures, and Forecast to 2033 Summary BRCA Tests Market Size (Value, Volume, ASP) by Segments, Share, Trend and SWOT Analysis, Regulatory and Reimbursement Landscape, P ... Read More
-
HER2 Tests Market Size (Value, Volume, ASP) by Segments, Share, Trend and SWOT Analysis, Regulatory and Reimbursement Landscape, Procedures, and Forecast to 2033
HER2 Tests Market Size (Value, Volume, ASP) by Segments, Share, Trend and SWOT Analysis, Regulatory and Reimbursement Landscape, Procedures, and Forecast to 2033 Summary HER2 Tests Market Size (Value, Volume, ASP) by Segments, Share, Trend and SWOT Analysis, Regulatory and Reimbursement Landscape, P ... Read More
-
Ewing Sarcoma Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
Ewing Sarcoma Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in Ewing Sarcoma therapeutics. There will be only 9,457 diagnosed prevalent cases of ES in 2023 in the ... Read More
-
BRAF Tests Market Size (Value, Volume, ASP) by Segments, Share, Trend and SWOT Analysis, Regulatory and Reimbursement Landscape, Procedures, and Forecast to 2033
BRAF Tests Market Size (Value, Volume, ASP) by Segments, Share, Trend and SWOT Analysis, Regulatory and Reimbursement Landscape, Procedures, and Forecast to 2033 Summary BRAF Tests Market Size (Value, Volume, ASP) by Segments, Share, Trend and SWOT Analysis, Regulatory and Reimbursement Landscape, P ... Read More
-
Colorectal Cancer Screening Tests Market Size (Value, Volume, ASP) by Segments, Share, Trend and SWOT Analysis, Regulatory and Reimbursement Landscape, Procedures, and Forecast to 2033
Colorectal Cancer Screening Tests Market Size (Value, Volume, ASP) by Segments, Share, Trend and SWOT Analysis, Regulatory and Reimbursement Landscape, Procedures, and Forecast to 2033 Summary Colorectal Cancer Screening Tests Market Size (Value, Volume, ASP) by Segments, Share, Trend and SWOT Analy ... Read More
-
Renal Cell Carcinoma Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update
Renal Cell Carcinoma Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update Summary GlobalData's clinical trial report, “Renal Cell Carcinoma Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, S ... Read More
Research Assistance
